WE SUPPORT AN INNOVATIVE ENVIRONMENT IN THE CZECH REPUBLIC

We are a family investment fund that sees value in the development and support of projects for the next generation. Our journey began in a small start-up, and through dedication and successes, we have transformed into an established company with an international business network. We are now using this evolution to put investment capital, courage and know-how into other innovative projects.

Get to know DENDIS CAPITAL

A FUND FOR NEW OPPORTUNITIES

IDEA
START-UP
INNOVATION
BIOTECH
LIFE SCIENCE
MEDTECH
SUPPORT
INVESTMENT
EDUCATION
PHARMA
DIAGNOSTICS
HEALTHCARE

WE ARE LOOKING FOR EXCEPTIONAL IDEAS AND NOVEL SOLUTIONS

We invest in established companies with growth potential and foster an environment of innovation by making smart investments in start-ups. We are particularly interested in projects applying innovative technologies in life science, diagnostics, medical devices, drug and vaccine development, telemedicine and the use of artificial intelligence in healthcare. We are not afraid of investing in biotechnology, but on the contrary, we see in it the greatest potential and opportunities for future generations. We offer our partners not only money, but also years of experience.

Contact us
Manželé Dendisovi, kteří vlastní nadační fond Dendis Capital

WE ENJOY SUPPORTING PURPOSEFUL PROJECTS

We are Miloš and Hana Dendis. As investors and founders of the foundation, we are fulfilling our angel dream and supporting the innovation environment in the Czech Republic. Our story began 18 years ago with the founding of GeneProof, which grew from a Czech start-up into a global player in the field of molecular diagnostics. Now we have decided to open a new chapter in our lives and make the most of the experience we have gained.

OUR INVESTMENTS

We help bring ideas to life and create an environment that fosters collaboration between scientists, experts and investors. Together, we want to cross borders for the benefit of human health. We are looking for those who will join us on a journey of discovery.

Will you be next?
htg medical logo

HTG Medical

Startup HTG Medical aims to simplify and streamline the work of medical staff not only in the ICU. Their innovative Urogram system replaces manual urine output measurements, saving nurses up to an hour a day while increasing patient comfort.

Go to website

AI|ffinity

AI|ffinity harnesses the power of NMR, artificial intelligence and cheminformatics to create disruptive solutions for the pharmaceutical and biotechnology industries. It aims to accelerate the early stages of drug discovery, increase success rates and reduce costs by eliminating unnecessary experiments.

Go to website

NuvinkaDx

NuvinkaDx, a global diagnostics company representing the Czech company GeneProof and the US company ALPCO, brings innovative, high-quality, user-friendly and reliable immuno- and molecular diagnostic solutions to laboratories worldwide.

Go to website

Alvie is a French startup that focuses on the efficient use of pesticides. It uses deep knowledge of pesticide dosing and advanced algorithms. The optimal application of pesticides allows to increase their efficiency and reduce doses.

Go to website

KARDI AI

Kardi AI's vision is to provide affordable at-home cardiac monitoring in the future, utilizing artificial intelligence to achieve performance comparable to an ECG from an inexpensive wearable device. This device will be readily available to the patient whenever needed.

Go to website

SCAUT

SCAUT helps you to verify the reliability of the information candidates provide during the selection process. Or regularly monitor employees in positions where it is needed. Online, automated and in seconds.

Go to website

SUPPORT

START YOUR BUSINESS

The Start Your Business competition is a suitable opportunity to validate your business plan or simply test your abilities and compare them with others.

TTDAY - TRANSFER TECHNOLOGY DAY

The competition of the most interesting Czech scientific research projects helps transfer discoveries and ideas into practice. In addition to the idea itself, the commercial potential of each project is also assessed.

PARTNERS

© Dendis Capital 2025